Bots, editor, reviewer, Administrators
13,951
edits
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
==December 2022== | ==December 2022== | ||
; [[Veterans Affairs Status Epilepticus Cooperative Study Group]]: New summary # | ; [[Veterans Affairs Status Epilepticus Cooperative Study Group]]: New summary #469: Antiepileptics in status epilepticus | ||
; [[VITAL (Vitamin D arm)]]: New summary # | ; [[VITAL (Vitamin D arm)]]: New summary #468: Vitamin D for cancer or CVD prevention | ||
==November 2022== | ==November 2022== | ||
; [[AID-ICU]]: New summary # | ; [[AID-ICU]]: New summary #467: Haloperidol for ICU delirium | ||
==October 2022== | ==October 2022== | ||
; [[DELIVER]]: New summary # | ; [[DELIVER]]: New summary #466: Dapagliflozin in HFmrEF or HFpEF | ||
; [[NordICC]]: New summary # | ; [[NordICC]]: New summary #465: Invitations for screening colonoscopy | ||
==September 2022== | ==September 2022== | ||
; [[ADVOR]]: New summary # | ; [[ADVOR]]: New summary #464: Acetazolamide vs. placebo in acute HF | ||
==August 2022== | ==August 2022== | ||
; [[TICORA]]: New summary # | ; [[TICORA]]: New summary #463: Intensive vs. standard treatment in early RA | ||
==July 2022== | ==July 2022== | ||
; [[NAVIGATE ESUS]]: New summary # | ; [[NAVIGATE ESUS]]: New summary #462: Rivaroxaban vs. ASA for ESUS (stroke) | ||
; [[NACSTOP]]: New summary # | ; [[NACSTOP]]: New summary #461: 12 vs. 20 hours of NAC in APAP overdose | ||
==June 2022== | ==June 2022== | ||
; [[CRB-401]]: New summary # | ; [[CRB-401]]: New summary #460: Ide-cel CART in myeloma | ||
==May 2022== | ==May 2022== | ||
; [[ESCAPe]]: New summary #459: Methylprednisolone vs. Placebo | |||
; Paternity leave | ; Paternity leave | ||
: Back in June! | : Back in June! |